[HTML][HTML] Plasmodium vivax in the era of the shrinking P. falciparum map
Plasmodium vivax is an important cause of malaria, associated with a significant public
health burden. Whilst enhanced malaria-control activities have successfully reduced the …
health burden. Whilst enhanced malaria-control activities have successfully reduced the …
[HTML][HTML] Plasmodium vivax–How hidden reservoirs hinder global malaria elimination
F Angrisano, LJ Robinson - Parasitology International, 2022 - Elsevier
Plasmodium vivax is the most geographically widespread human malaria parasite. Global
malaria efforts have been less successful at reducing the burden of P. vivax compared to P …
malaria efforts have been less successful at reducing the burden of P. vivax compared to P …
Advances and roadblocks in the treatment of malaria
B Hanboonkunupakarn, NJ White - British journal of clinical …, 2022 - Wiley Online Library
The deployment of artesunate for severe malaria and the artemisinin combination therapies
(ACTs) for uncomplicated malaria has been a major advance in antimalarial therapeutics …
(ACTs) for uncomplicated malaria has been a major advance in antimalarial therapeutics …
[HTML][HTML] G6PD variants and haemolytic sensitivity to primaquine and other drugs
G Bancone, CS Chu - Frontiers in Pharmacology, 2021 - frontiersin.org
Restrictions on the cultivation and ingestion of fava beans were first reported as early as the
fifth century BC. Not until the late 19th century were clinical descriptions of fava-induced …
fifth century BC. Not until the late 19th century were clinical descriptions of fava-induced …
[HTML][HTML] A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria
Plasmodium vivax malaria continues to cause a significant burden of disease in the Asia-
Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8 …
Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8 …
Risk of bias assessments in individual participant data meta-analyses of test accuracy and prediction models: a review shows improvements are needed
Objective Risk of bias assessments are important in meta-analyses of both aggregate and
individual participant data (IPD). There is limited evidence on whether and how risk of bias …
individual participant data (IPD). There is limited evidence on whether and how risk of bias …
[HTML][HTML] Repeatability and reproducibility of a handheld quantitative G6PD diagnostic
Background The introduction of novel short course treatment regimens for the radical cure of
Plasmodium vivax requires reliable point-of-care diagnosis that can identify glucose-6 …
Plasmodium vivax requires reliable point-of-care diagnosis that can identify glucose-6 …
[HTML][HTML] Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
Background In 2017, an estimated 14 million cases of Plasmodium vivax malaria were
reported from Asia, Central and South America, and the Horn of Africa. The clinical burden of …
reported from Asia, Central and South America, and the Horn of Africa. The clinical burden of …
Current investigations on clinical pharmacology and therapeutics of glucose-6-phosphate dehydrogenase deficiency
K Ryan, BL Tekwani - Pharmacology & therapeutics, 2021 - Elsevier
Abstract Glucose-6-phospate dehydrogenase (G6PD) deficiency is estimated to affect more
than 400 million people world-wide. This X-linked genetic deficiency puts stress on red …
than 400 million people world-wide. This X-linked genetic deficiency puts stress on red …
[HTML][HTML] Usability of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and …
E Gerth-Guyette, W Adissu, M Brito, E Garbin… - Malaria journal, 2021 - Springer
Background Point-of-care glucose-6-phosphate dehydrogenase (G6PD) testing has the
potential to make the use of radical treatment for vivax malaria safer and more effective …
potential to make the use of radical treatment for vivax malaria safer and more effective …